Walleye Capital
GILD icon

Walleye Capital’s Gilead Sciences GILD Stock Holding History

Walleye Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Sell
132,900
-106,600
-45% -$14.9M 0.08% 220
2025
Q4 		$29.4M Buy
239,500
+105,600
+79% +$12.8M 0.09% 165
2025
Q3 		$14.9M Sell
133,900
-37,900
-22% -$4.31M 0.06% 364
2025
Q2 		$19M Buy
171,800
+84,900
+98% +$9.04M 0.07% 251
2025
Q1 		$9.74M Sell
86,900
-26,400
-23% -$2.72M 0.04% 455
2024
Q4 		$10.5M Buy
113,300
+60,200
+113% +$5.42M 0.03% 602
2024
Q3 		$4.45M Sell
53,100
-3,700
-7% -$282K 0.01% 1258
2024
Q2 		$3.9M Sell
56,800
-50,100
-47% -$3.34M 0.01% 1489
2024
Q1 		$7.83M Sell
106,900
-86,200
-45% -$6.63M 0.01% 986
2023
Q4 		$15.6M Sell
193,100
-28,000
-13% -$2.18M 0.03% 450
2023
Q3 		$16.6M Buy
221,100
+145,600
+193% +$11.2M 0.04% 333
2023
Q2 		$5.82M Buy
75,500
+53,900
+250% +$4.3M 0.02% 648
2023
Q1 		$1.79M Sell
21,600
-15,100
-41% -$1.25M 0.03% 789
2022
Q4 		$3.15M Buy
36,700
+25,500
+228% +$2.02M 0.06% 397
2022
Q3 		$691K Buy
+11,200
New +$706K 0.01% 1222
2020
Q2 		– Sell
-500
Closed -$37K – 748
2020
Q1 		$37K Sell
500
-27,300
-98% -$1.89M 0.01% 715
2019
Q4 		$1.81M Sell
27,800
-66,500
-71% -$4.33M 0.12% 230
2019
Q3 		$5.98M Buy
94,300
+84,600
+872% +$5.53M 0.36% 40
2019
Q2 		$655K Sell
9,700
-7,000
-42% -$460K 0.07% 396
2019
Q1 		$1.09M Buy
+16,700
New +$1.11M 0.18% 139

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Walleye Capital's GILD Position: Q1 2026 in Review

Walleye Capital increased its Gilead Sciences (GILD) stake by 552% in Q1 2026, buying an estimated $17.9M and bringing the position to 150,967 shares worth $21M. The position accounts for 0.09% of the portfolio, ranked #179.

Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Walleye Capital held 150,967 shares of Gilead Sciences worth $21M as of Q1 2026.
  • Walleye Capital bought 127,817 Gilead Sciences shares in Q1 2026, an estimated $17.9M.
  • Gilead Sciences made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #179 holding.
  • Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.